Carevive’s Longitudinal Data

At Carevive, our commitment to enhancing cancer care through data-driven insights is at the core of our mission. Our real-time, longitudinal data set offers comprehensive and up-to-date information on patient experiences throughout their cancer journey.

With over 1,700 patients represented across 26 cancer types, our registry provides a wealth of information from more than 19,000 completed surveys conducted over two years. This rich dataset encompasses over 600,000 unique data points, providing valuable information for analysis and personalized care planning.

One of the key strengths of our approach is seamless integration with the care process. Our surveys are presented to patients by their care teams, ensuring an outstanding survey response rate of 82% or higher for some indications. This compliance underscores the importance of patient engagement in the treatment process.

Carevive’s real-time data empowers care teams with valuable insights, enabling them to make informed decisions, proactively address patient concerns, and optimize treatment plans. Our commitment to advancing cancer care through data excellence sets the stage for continued innovation and improved patient outcomes.

Recent Episodes

In this episode of Care Anywhere: The Global Health Workforce Podcast, host Lea Sims welcomes Syl Trepanier, DNP, RN, Chief Nursing Officer for Providence Health and member of the TruMerit Board of Trustees. With responsibility for representing more than 36,000 nurses across a multi-state health system, Syl shares his personal journey from caregiving as…

The accelerator model is undergoing a transformation, and at the center of this change is HealthTech Arkansas, a powerful program that’s redefining the traditional approach by guaranteeing clinical pilots for healthcare startups. As the healthcare system faces a mounting burden from chronic disease (cardiovascular-related costs alone are projected to reach a staggering $1.8 trillion…

Michael Rothman explores the complexities of sepsis identification and management, highlighting the challenges posed by varying definitions and clinical pathways. He discusses the ineffectiveness of current sepsis screening protocols, which often yield high false-positive rates and fail to reduce mortality meaningfully. The episode concludes by questioning the focus on sepsis-specific initiatives and suggesting that more…